These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22202402)

  • 1. [A case of distal cholangiocarcinoma with high sensitivity to neoadjuvant chemoradiation therapy].
    Haji Y; Mizuma M; Hayashi H; Nakagawa K; Okada T; Otsuka H; Ottomo S; Sakata N; Fukase K; Yoshida H; Onogawa T; Motoi F; Naito T; Rikiyama T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2426-8. PubMed ID: 22202402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy].
    Yamada K; Sakamoto K; Tamesa T; Matsui H; Shindo Y; Tokumitsu Y; Hashimoto N; Iida M; Maeda Y; Tokuhisa Y; Suzuki N; Yoshimura K; Ueno T; Takahashi M; Shibuya K; Kondo T; Oka M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1756-8. PubMed ID: 24393912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis].
    Nakagawa K; Katayose Y; Unno M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study).
    Katayose Y; Rikiyama T; Motoi F; Yamamoto K; Yoshida H; Morikawa T; Hayashi H; Kanno A; Hirota M; Satoh K; Ariga H; Suzuki M; Ohyauchi M; Kondo Y; Ikeya S; Ogawa Y; Shimosegawa T; Egawa S; Unno M
    Hepatogastroenterology; 2011; 58(112):1866-72. PubMed ID: 22234055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
    Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
    Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possibility of local control of cancer by neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma].
    Nakagawa K; Katayose Y; Rikiyama T; Okaue A; Unno M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2009-11. PubMed ID: 20037307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
    Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of cholangiectasis with cholangiocarcinoma].
    Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K; Wang HL
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal cholangiocarcinoma.
    Lad N; Kooby DA
    Surg Oncol Clin N Am; 2014 Apr; 23(2):265-87. PubMed ID: 24560110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal biliary malignancy.
    Veillette G; Castillo CF
    Surg Clin North Am; 2008 Dec; 88(6):1429-47, xi. PubMed ID: 18992603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
    Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resection of cholangiolocellular carcinoma successfully responding to neoadjuvant hepatic arterial infusion chemotherapy - report of a case].
    Nakayama Y; Nakamura N; Ito T; Matsubayashi J; Yogo A; Kitou Y; Hanamoto K; Ura K; Taira K; Oe H; Yoshikawa A; Mitsuyoshi A; Ishigami S; Shirase T; Doi R
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1155-7. PubMed ID: 22790060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
    Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
    Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.